Department of Medicine, Division of General Internal Medicine and Health Services Research, University of California, Los Angeles, CA.
Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, CA.
Med Care. 2024 Oct 1;62(10):693-700. doi: 10.1097/MLR.0000000000002025. Epub 2024 Sep 6.
Given the many challenges of conducting research that addresses the palliative and end-of-life care needs of patients with serious illnesses, stakeholder engagement starting from the moment of study conceptualization and design is critical to ensure successful participant recruitment, data collection, intervention delivery, data analysis, and dissemination.
Guided by a conceptual model published by the Patient-Centered Outcomes Research Institute (PCORI) entitled, "Measuring What Matters for Advancing the Science and Practice of Engagement"14 and with the support of a PCORI Engagement Officer, representatives from 9 PCORI-funded study teams formed a working group to survey team members and review, outline, and describe key lessons learned and best practices for promoting stakeholder engagement in palliative care research.
Almost all study teams engaged with patients/caregivers, clinicians, researchers, and health care system experts as stakeholder partners. About half the teams also included payers and training institutions as part of their stakeholder advisors as well as a range of content experts. Study teams relied on a variety of support structures and resources, and they employed 10 distinct methods for maintaining engagement. All engagement methods were generally considered to be effective by teams who used the method, though there was some variability in team-rated engagement quality of each method. Nine barriers to stakeholder engagement were identified across the 9 studies as well as 9 strategies (or facilitators) to overcome these barriers. We share examples of how stakeholder engagement impacted studies in all phases, including the preparatory phase, study initiation phase, execution phase, and data analysis/dissemination phase.
Teams utilized a variety of resources and support structures as well as capitalized on multiple engagement methods for fostering stakeholder engagement, resulting in a high level of collaboration and integration.
鉴于开展研究以满足患有严重疾病患者的姑息治疗和临终关怀需求所面临的诸多挑战,从研究概念化和设计阶段开始,让利益相关者参与进来对于确保成功招募参与者、收集数据、实施干预措施、分析数据以及传播研究结果至关重要。
在患者中心的结局研究协会(PCORI)发布的题为“衡量对推进参与式科学和实践有重要意义的内容”的概念模型的指导下,并在 PCORI 参与官员的支持下,来自 9 个 PCORI 资助研究团队的代表组成了一个工作组,对团队成员进行了调查,并回顾、概述和描述了在姑息治疗研究中促进利益相关者参与的关键经验教训和最佳实践。
几乎所有的研究团队都将患者/照顾者、临床医生、研究人员和医疗保健系统专家作为利益相关者伙伴进行了接触。大约一半的团队还将支付方和培训机构作为利益相关者顾问的一部分纳入其中,同时还包括一系列的内容专家。研究团队依靠各种支持结构和资源,并采用 10 种不同的方法来维持参与。所有的参与方法在使用该方法的团队中都被认为是有效的,尽管团队对每种方法的参与质量评价存在一定的差异。在 9 项研究中确定了 9 个利益相关者参与障碍,以及克服这些障碍的 9 个策略(或促进因素)。我们分享了利益相关者参与如何在所有阶段影响研究的例子,包括准备阶段、研究启动阶段、执行阶段和数据分析/传播阶段。
团队利用了各种资源和支持结构,并利用多种参与方法促进利益相关者的参与,从而实现了高水平的合作和整合。